Strides Arcolab received a nod by the US FDA for an Oncology unit in Bengaluru. Arun Kumar, group CEO and vice chairman of Strides Arcolab, in an exclusive interview with CNBC-TV18 shares that the company expects approvals on approximately USD 4-5 billon product filings in the next few weeks.
first published: May 2, 2011 12:58 pm
A collection of the most-viewed Moneycontrol videos.
Live: Market breadth weakens, India VIX jumps as Iran-US ceasefire hangs | Closing Bell
IEX Stock Crash Explained | CERC’s New Rule Shakes Power Market
LIVE | US Navy seizes Iranian ship; talks uncertain; Nifty 200 DMA key, bank earnings focus now!
Iran Rejects US Talks Again, Strait Of Hormuz Tensions Rise As Oil Route Risks Grow
